Author:
Ende H.B.,French B.,Shi Y.,Dertai M.D.,Osmundson S.S.,Bauchat J.R.
Abstract
(Int J Obstet Anesth. 2022;51:103550)
As 2.5% of births in the United States are impacted by uterine atony, identifying high-risk women can promote timely treatment and subsequently minimize adverse outcomes. However, there is no current risk assessment model that solely focuses on the risk for uterine atony rather than the overall risk for postpartum hemorrhage (PPH). This retrospective study created and tested 2 risk prediction models for antepartum and intrapartum uterine atony.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Complementary and alternative medicine,Pharmaceutical Science